Latest news
Loading news…
evonetix
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Little Chesterford, Essex, United Kingdom Founded 2015 101-250 employees For Profit
Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
25
Patents
17
4 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Active products
- 17
- Patents granted
- 17
- Trademarks
- 4
- IT spend
- $493K
Company Info
- Founded
- 2015
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 42
- HQ
- Little Chesterford, Essex, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0.4
- Trend (30d)
- 4.1
- Trend (90d)
- -0.3
- Last leadership hire
- Jun 13, 2022
Key People at evonetix
CTO
Senior Scientist
Chief Scientific Officer
Chief Executive Officer
25
professional contacts at evonetix
Contact execs at evonetix →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to evonetix
Loading news…
FAQs about evonetix
People who checked this page also checked these
Browse the full Acquirezy directory.